Delivery Order SPE2DB22D1106-SPE2DB25FDWL7
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,752,422 units of the antibiotic moxifloxacin hydrochloride 400 mg tablets, with a completion date of May 31, 2024 and a ceiling value of $1,364.84. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026, enabling efficient...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,423.55 and an ultimate completion date of August 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,564,591,767 units of Moxifloxacin HCL 400 mg tablets, at a firm fixed price of $9,625.18. The contract has a completion date of May 14, 2024 and was awarded on May 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,104.21 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565457340 moxifloxacin HCL 400 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,567,049,952 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,342.70 and is a firm fixed price delivery order without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,013.60 firm fixed-price contract is for the delivery of 4,564,603,860 tablets of the antibiotic moxifloxacin hydrochloride 400 milligrams. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4563954862 - moxifloxacin hydrochloride 400 mg tablets. The contract has a ceiling value of $2,010.89 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.62, is for the delivery of Moxifloxacin HCL 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply MOXIFLOXACIN HCL 400 MG TABLET 30S to the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $11,387.37 and a completion date of April 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...